Merck is modernizing its drug discovery process using Amazon Web Services (AWS) with the integration of biological foundation models. Learn how Merck improved its drug research efficiency by implementing AWS HealthOmics, solving a challenge of managing intricate protein design processes. 

Learn firsthand experience into how Merck modernized its generative biology inference stack using AWS HealthOmics, which helps them scale and unlock new insights. 

Key points covered:

• Accelerate discovery: Combines multiple artificial intelligence (AI) models in a streamlined pipeline to generate thousands of protein designs.

• Enhanced productivity: Enable research teams to focus on mechanisms that drive innovation.

• Scalable infrastructure: AWS HealthOmics, a HIPAA-eligible service, scales to process tens of thousands of samples, adjusting resources based on workload demands.

Watch this video to see how Merck is improving drug design with AWS HealthOmics and see how your organization can accelerate innovation with AWS.